Selexis CHO Cells in Suspension-1

Latest News

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

NOVEMBER 1, 2021
3 min read

Meet Selexis During Key Industry Conferences to Learn About the Latest Innovations in Cell Line Development

Geneva, Switzerland, November 1, 2021Selexis SA, a JSR Life Sciences company, today announced that business and...

Read More
JUNE 29, 2021
3 min read

Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

Geneva, Switzerland, and Durham, NC – June 29, 2021Selexis SA and KBI Biopharma (KBI), both JSR Life Sciences...

Read More
JUNE 1, 2021
2 min read

Selexis Appoints Roland Hoffmann-Hecht, PhD, as Chief Business Officer

Business Development Executive in Biologics Drug Development and Manufacturing Brings More than 25 Years of...

Read More